文献速递血管炎

巨细胞动脉炎发病机制的新见解:它们与精准医学相关吗?

New insights into the pathogenesis of giant cell arteritis: are they relevant for precision medicine?
PubMed 文献 · Lancet Rheumatol · 2021-10-28

本文为综述,围绕巨细胞动脉炎发病机制的最新证据展开,指出该病好发于50岁以上人群、对大型和中型血管有严格组织趋向性,但特定触发因素与慢性损伤机制尚未明确。文章提出以发病机制为中心,利用颞动脉活检探索不同疾病表型,以服务于精准医学的分层与治疗反应预测。

要点

  • 巨细胞动脉炎是主要累及大型和中型血管的肉芽肿性血管炎,发生于50岁以上人群。
  • 特定触发因素与慢性损伤机制尚未明确,多种细胞与细胞因子间的促炎层级关系仍属未探索领域。
  • 精准医学的前提是基线识别临床、影像与分子生物标志物以分层患者并预测治疗反应。

核心结论

  • 过去10年对巨细胞动脉炎部分病理生理机制的认识有相当进展,但特定触发因素与慢性损伤机制尚未明确。
  • 多种细胞类型与不同细胞因子或趋化因子之间的特定促炎层级关系仍属未探索的研究领域。
  • 因诊断目的获取颞动脉活检为定义不同疾病表型提供了探索可能,这些表型可能对不同的治疗干预敏感。

研究设计与样本

  • 本文为系列综述(Series paper),描述与巨细胞动脉炎发病机制相关的最新证据,并尝试定义以发病机制为中心的新方法。

主要发现

  • 巨细胞动脉炎是对大型和中型血管有严格组织趋向性的原发性肉芽肿性血管炎,发生于50岁以上人群。
  • 精准医学的总体目标是为患有特定疾病的个体或群体确定尽可能最佳的治疗方法。
  • 精准医学方法的基本前提是在基线识别临床与影像表现及分子生物标志物,以实现患者精准分层和治疗反应的充分预测。

关键数值与推荐

  • 原文未报告具体诊断标准、推荐条款或数值阈值。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 特定触发因素与慢性损伤机制尚未明确。
  • 多种细胞类型与不同细胞因子或趋化因子之间的特定促炎层级关系仍属未探索领域。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Giant cell arteritis is a primary granulomatous vasculitis characterised by a strict tissue tropism for large and medium-size vessels, occurring in people older than 50 years. Although considerable progress in understanding some of the pathophysiological mechanisms involved in the pathogenesis of giant cell arteritis has been made in the past 10 years, specific triggers of disease and mechanisms of chronic damage have not yet been identified. The definition of a specific pro-inflammatory hierarchy between the multiple cell types and the different cytokines or chemokines involved in the inflammatory process are still unexplored areas of study. The overall goal of precision medicine is to identify the best possible therapeutic approach for an individual or group of individuals with a given disease. The fundamental prerequisite of this approach is the identification, at baseline, of clinical and imaging findings and of molecular biomarkers that allow a precise stratification of patients and an adequate prediction of the therapeutic response. In this regard, the possibility of obtaining temporal artery biopsies for diagnostic purposes offers incredible exploratory possibilities to define different disease pathotypes potentially susceptible to different therapeutic interventions. In this Series paper, we will describe the most recent evidence relating to the pathogenesis of giant cell arteritis, trying to define, if possible, a new pathogenetic-centred approach to patients with giant cell arteritis.

来源:Lancet Rheumatol,查看原文。版权归原作者所有。

引用

  1. Ciccia F, Macaluso F, Mauro D, et al. New insights into the pathogenesis of giant cell arteritis: are they relevant for precision medicine? Lancet Rheumatol. 2021. PMID: 38287633. doi:10.1016/S2665-9913(21)00253-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。